Subcellular expression pattern and clinical significance of CBX2 and CBX7 in breast cancer subtypes

Chromobox (CBX)2 and CBX7, members of CBX family protein, show diverse expression patterns and contrasting roles in certain cancers. We aimed to investigate the subcellular expression patterns and clinical significances of CBXs in breast cancer (BC) subtypes, which have heterogeneous clinical course...

Full description

Saved in:
Bibliographic Details
Published in:Medical molecular morphology 2024-03, Vol.57 (1), p.11-22
Main Authors: Park, Sungjoon, Choi, Jaehyuck, Song, Jung-Kook, Jang, Bogun, Maeng, Young Hee
Format: Article
Language:English
Subjects:
Anatomy
Androgen receptors
Breast cancer
Down-regulation
Immunohistochemistry
Invasiveness
Medicine
Medicine & Public Health
Metastases
Molecular Medicine
Original Paper
Pathology
Therapeutic targets
Tumorigenesis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chromobox (CBX)2 and CBX7, members of CBX family protein, show diverse expression patterns and contrasting roles in certain cancers. We aimed to investigate the subcellular expression patterns and clinical significances of CBXs in breast cancer (BC) subtypes, which have heterogeneous clinical course and therapeutic responses. Among the subtypes, the triple-negative BC (TNBC) is a heterogeneous group that lacks specific markers. We categorized TNBC into quadruple-negative BC (QNBC) and TNBC, based on androgen receptor (AR) status, to make the groups more homogeneous. Immunohistochemistry for CBX proteins was performed on 323 primary invasive BC tissues and their clinical significances were analyzed. Cytoplasmic CBX2 (CBX2-c) was linked to adverse clinicopathological factors and TNBC and QNBC subtypes. In contrast, nuclear CBX7 (CBX7-n) was associated with favorable parameters and luminal A subtype. CBX2-c expression increased progressively from that in benign lesions to that in in situ carcinomas and invasive cancers, whereas CBX7-n and AR expressions showed sequential downregulation. AR was lower in metastatic tissues compared to matched primary cancer tissues. We speculate that the upregulation of CBX2-c and downregulation of CBX7-n could play a role in breast oncogenesis and an adverse clinical course, suggesting them as potential prognostic markers and therapeutic targets in invasive BCs.
ISSN:1860-1480
1860-1499
DOI:10.1007/s00795-023-00368-7